Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Novavax reports phase III data from U.K. trial of COVID-19 vaccine NVX-CoV2373

Jan. 29, 2021

RSV vaccine candidate GSK-3844766A advances into phase IIb extension study

Jan. 28, 2021

BioVaxys announces advances in its vaccine platforms

Jan. 27, 2021

Dosing begins in phase II study of MVC-COV-1901 vaccine in Taiwan

Jan. 26, 2021

Progen presents new fusion proteins for autoimmune diseases

Jan. 26, 2021

New IL-10 variant proteins presented by Korean investigators

Jan. 25, 2021

Cellular underpinnings of allergen immunotherapy success

Jan. 18, 2021

Antibody protects broadly against flaviviruses, without ADE

Jan. 12, 2021

E.U. approval for Xofluza for treatment and postexposure prophylaxis of influenza

Jan. 11, 2021

U.K. approval of COVID-19 Vaccine Moderna

Jan. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...